Crossmark

Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study

Crossref DOI link: https://doi.org/10.1007/s12325-016-0374-x

Published Online: 2016-07-18

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sakurai, Yuuichi

Shiino, Madoka

Okamoto, Hiroyuki

Nishimura, Akira

Nakamura, Koki

Hasegawa, Setsuo
Funding

Funding for this research was provided by:

Takeda Pharmaceutical Company
License Information

Text and Data Mining valid from 2016-07-18

Version of Record valid from 2016-07-18
More Information

Article History

Received: 8 April 2016

First Online: 18 July 2016

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below